Hemodialysis

Global Dialysis Devices and Equipment Market Report 2020: Market is Expected to Recover and Reach $19.5 Billion in 2023 - Forecast to 2030

Retrieved on: 
Tuesday, January 19, 2021
Medicine, Clinical medicine, Membrane technology, Renal dialysis, Renal replacement therapy, Kidney diseases, Dialysis, Hemodialysis, Hemofiltration, Nephrology, Acute kidney injury, Kidney

The market is then expected to recover and grow at a CAGR of 8.7% from 2021 and reach $19,591.8 million in 2023.

Key Points: 
  • The market is then expected to recover and grow at a CAGR of 8.7% from 2021 and reach $19,591.8 million in 2023.
  • The dialysis devices and equipment is segmented by product into hemodialysis devices, peritoneal devices, consumables and continuous renal replacement therapy (CRRT).
  • The global dialysis devices and equipment is concentrated, with a small number of large players in the market.
  • However, the COVID-19 infection can increase the risk of acute kidney injury can positively affect the dialysis devices and equipment market.

$29 Billion Dialysis Devices and Equipment Market - Global Opportunities and Strategies to 2030: COVID-19 Impact and Recovery - ResearchAndMarkets.com

Retrieved on: 
Monday, January 18, 2021
Medical devices, Health, Medicine, Clinical medicine, Membrane technology, Renal replacement therapy, Dialysis, Hemodialysis, Hemofiltration, Acute kidney injury, Home hemodialysis, Liver support system

The "Dialysis Devices and Equipment Global Market Opportunities and Strategies to 2030: COVID-19 Impact and Recovery" report has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • The "Dialysis Devices and Equipment Global Market Opportunities and Strategies to 2030: COVID-19 Impact and Recovery" report has been added to ResearchAndMarkets.com's offering.
  • The dialysis devices and equipment is segmented by product into hemodialysis devices, peritoneal devices, consumables and continuous renal replacement therapy (CRRT).
  • Player-adopted strategies in the dialysis devices and equipment include expanding through strategic acquisitions and expansion through the launch of new devices.
  • However, the COVID-19 infection can increase the risk of acute kidney injury can positively affect the dialysis devices and equipment market.

Quanta Receives FDA 510(k) Clearance for the SC+ Hemodialysis System Setting the Stage for US Market Launch

Retrieved on: 
Friday, January 8, 2021
Medicine, Membrane technology, Clinical medicine, Nephrology, Medical specialties, Renal dialysis, Quanta, Hemodialysis, Dialysis, Kidney failure

Kidney failure is one of the costliest health conditions for the American health system.

Key Points: 
  • Kidney failure is one of the costliest health conditions for the American health system.
  • This will be a pivotal year for Quanta as we build our US presence and bring our next generation hemodialysis system to a community ripe with need.
  • In preparation for commercial launch, Quanta continues to develop its US team and operations.
  • The versatility,portability and simplicity of this device, combined with amodular approach to water purification, offersomething for many different care environments.

Kidney-Friendly, Home-Delivered Meals Provided by Mom’s Meals Reduces Key Disease Markers in Hemodialysis Patients

Retrieved on: 
Tuesday, January 5, 2021
Retail, Diabetes, Other Health, Oncology, Managed care, General Health, Online Retail, Other Retail, Fitness & Nutrition, Restaurant, Bar, Clinical trials, Cardiology, Specialty, Food, Beverage, Health, Medicine, Membrane technology, Renal dialysis, Hemodialysis, Dialysis, Retail, Diabetes, Other Health, Oncology, Managed care, General Health, Online Retail, Other Retail, Fitness & Nutrition, Restaurant, Bar, Clinical trials, Cardiology, Specialty, Food, Beverage, Health, Medicine, Membrane technology, Renal dialysis, Hemodialysis, Dialysis

Moms Meals , a leading, national provider of home-delivered meals, announces today results of a study published by Hemodialysis International evaluating the impact of home-delivered meals to help support reduction in dietary sodium and meet health goals among hemodialysis (HD) patients.

Key Points: 
  • Moms Meals , a leading, national provider of home-delivered meals, announces today results of a study published by Hemodialysis International evaluating the impact of home-delivered meals to help support reduction in dietary sodium and meet health goals among hemodialysis (HD) patients.
  • The study results show that kidney-friendly, home-delivered meals are an effective approach to improving volume control and blood pressure of these patients.
  • The study monitored 20 qualifying HD patients who followed a usual (control) diet for the first four weeks followed by four weeks of three low-sodium, home-delivered meals per day (provided by Moms Meals).
  • Mike Anderson, president of Moms Meals, reacted to the study results, We were delighted to see the promising results from this investigator-driven clinical trial.

Insights on the Hemodialysis Equipment Market 2020-2024: COVID-19 Industry Analysis, Market Trends, Market Growth, Opportunities and Forecast 2024 - Technavio

Retrieved on: 
Monday, January 4, 2021
Health, Nursing, Medical devices, Medicine, Clinical medicine, Renal dialysis, Membrane technology, Medical specialties, Nephrology, Home hemodialysis, Hemodialysis, Dialysis

The hemodialysis equipment market share growth by the in-center hemodialysis segment will be faster than the growth of the market by the home hemodialysis segment.

Key Points: 
  • The hemodialysis equipment market share growth by the in-center hemodialysis segment will be faster than the growth of the market by the home hemodialysis segment.
  • Europe was the largest hemodialysis equipment market in 2019, and the region will offer several growth opportunities to market vendors during the forecast period.
  • The adoption of advanced hemodialysis equipment, increasing prevalence of kidney diseases, the growing healthcare expenditure, and favorable reimbursement will significantly drive hemodialysis equipment market growth in this region over the forecast period.
  • Market growth in this region will be slower than the growth of the market in Asia.

Cara Therapeutics Submits New Drug Application to U.S. Food and Drug Administration for KORSUVA™ Injection in Hemodialysis Patients with Moderate-to-Severe Pruritus

Retrieved on: 
Monday, December 28, 2020
Membrane technology, Medicine, Renal dialysis, Hemodialysis, Dialysis

Cara has requested Priority Review for the NDA which, if granted, could result in a six-month review process.

Key Points: 
  • Cara has requested Priority Review for the NDA which, if granted, could result in a six-month review process.
  • The FDA has a 60-day filing review period to determine whether the NDA is complete and acceptable for filing.
  • The NDA submission for KORSUVA Injection marks a significant milestone for Cara and for hemodialysis patients who suffer from intractable pruritus, said Derek Chalmers, Ph.D., D.Sc., President and Chief Executive Officer of Cara Therapeutics.
  • Pisoni RL, et al.Pruritus in hemodialysis patients: international results from the Dialysis Outcomes and Practice Patterns Study.Nephrol Dial Transplant.2006; 21:3495-3505.

$116 Billion Hemodialysis Market - Global Opportunity Analysis and Industry Forecast to 2030 - ResearchAndMarkets.com

Retrieved on: 
Wednesday, December 9, 2020
Retail, Other Retail, Membrane technology, Medicine, Renal dialysis, Hemodialysis, Dialysis

The "Hemodialysis Market by Product & Service, Type, End User - Global Opportunity Analysis and Industry Forecast, 2020-2030" report has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • The "Hemodialysis Market by Product & Service, Type, End User - Global Opportunity Analysis and Industry Forecast, 2020-2030" report has been added to ResearchAndMarkets.com's offering.
  • The Global Hemodialysis Market was valued at USD 78.30 billion in 2019 and is estimated to reach USD 116.66 billion by 2030, expanding at a CAGR of 3.60% during the forecast period, from 2020 to 2030.
  • Market Segmentations and Scope of the Study:
    The hemodialysis market has been divided in terms of product & service, type, end user, and geography.
  • Therefore, the region accounts for a dominate share of the global hemodialysis market.

Medtronic Launches the First and Only Pediatric and Neonatal Acute Dialysis Machine in the U.S.

Retrieved on: 
Tuesday, December 8, 2020
Medicine, Clinical medicine, Membrane technology, Medical specialties, Kidney diseases, Organ failure, Acute kidney injury, Renal dialysis, Hemofiltration, Dialysis, Hemodialysis, Renal replacement therapy

The first of its kind Carpediem system is indicated for use in acute kidney injury or fluid overloaded patients requiring hemodialysis or hemofiltration therapy.

Key Points: 
  • The first of its kind Carpediem system is indicated for use in acute kidney injury or fluid overloaded patients requiring hemodialysis or hemofiltration therapy.
  • The mortality rate for neonates with acute kidney injury has been reported to be as high as 60 percent.
  • "This new system is designed specifically for these patients which enables increased precision of neonatal CRRT treatment and, potentially, reduces these risks.
  • Developing a neonatal acute kidney injury research definition: a report from the NIDDK neonatal AKI workshop.

Stanford Surgeon Venita Chandra Joins Alucent Biomedical Scientific Advisory Board as Company Enters Arteriovenous Fistula Market

Retrieved on: 
Tuesday, December 8, 2020
Medical devices, Health, Surgery, Pharmaceutical, Cardiology, Biotechnology, Medicine, Clinical medicine, Renal dialysis, AVF, Arteriovenous fistula, Arteriovenous, Fistula, NVS, Avera Health, Hemodialysis, Cimino fistula

Alucent Biomedical , a privately held medical technology company founded to transform the way vascular disease is treated, today announced Venita Chandra, M.D.

Key Points: 
  • Alucent Biomedical , a privately held medical technology company founded to transform the way vascular disease is treated, today announced Venita Chandra, M.D.
  • The company announced today it will also seek to adapt the technology for another use, the maturation and preservation of arteriovenous fistula (AVF) for hemodialysis (HD).
  • Applying the treatment at fistula creation has facilitated maturation and the promotion of outward remodeling of the AVF, Dr. Chandra said.
  • Alucent was founded by Avera Health to develop and market products using Alucent Natural Vascular Scaffolding (Alucent NVS) technology.

South and Central America Portable and Wearable Dialysis Devices Market Forecast to 2027 - COVID-19 Impact and Regional Analysis by Product Type ; End users, and Country

Retrieved on: 
Tuesday, November 24, 2020
Medicine, Clinical medicine, Medical specialties, Renal dialysis, Membrane technology, Nephrology, Dialysis, Hemodialysis, End Stage Renal Disease Program, Peritoneal dialysis, Kidney failure, Northwest Kidney Centers

The growth of the South and Central America and portable and wearable dialysis devices market is attributed to the growing prevalence of chronic kidney conditions and end stage renal diseases.Further, increasing geriatric population and rising wearable dialysis device adoption are also projected to drive the market growth during the forecast period.

Key Points: 
  • The growth of the South and Central America and portable and wearable dialysis devices market is attributed to the growing prevalence of chronic kidney conditions and end stage renal diseases.Further, increasing geriatric population and rising wearable dialysis device adoption are also projected to drive the market growth during the forecast period.
  • Technological advancements in dialysis devices are also anticipated to accelerate the market growth in the coming years.The outbreak of the COVID-19 pandemic is estimated to have substantial impact on the portable and wearable dialysis device market.
  • Such shortage of organ transplantation might lead to adoption of wearable and portable dialysis devices, leading to growth of the market.
  • Based on product type, the South and Central America portable and wearable dialysis devices market is segmented into hemodialysis and peritoneal dialysis.